Population pharmacokinetics of digoxin in japanese patients: A 2-compartment pharmacokinetic model

Clinical Pharmacokinetics

Volumn 40, Issue 10, 2001, Pages 773-781

  Yukawa, E ^a   Suematu, F ^b   Yukawa, M ^c   Minemoto, M ^b   Ohdo, S ^a   Higuchi, S ^a   Goto, Y ^c   Aoyama, T ^d  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU KOSEI NENKIN HOSPITAL   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; DIGOXIN; DILTIAZEM; NICARDIPINE; NIFEDIPINE; SPIRONOLACTONE; VERAPAMIL;

ADULT; AGED; ARTICLE; COMPARTMENT MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG INHIBITION; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 0034754009     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200140100-00005     Document Type: Article

References (30)

1. Digitalis: An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations
2. Clinical pharmacokinetics of digoxin
3. Clinical pharmacokinetics of digoxin
4. Serum concentration monitoring of cardiac glycosides: How helpful is it for adjusting dosage regimens?
5. Digoxin pharmacokinetics: Role of renal failure in dosage regimen design
6. Pharmacokinetics of digoxin: Comparison of a two- and three-compartment model in man
7. A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses
8. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling
9. Some suggestions for measuring predictive performance
10. A standard approach to compiling clinical pharmacokinetic data
11. 2+ antagonists and digoxin
12. Effect of co-administration of verapamil and qinidine on serum digoxin concentration
13. Digoxin-verapamil interaction
14. The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects
15. The influence of verapamil on serum digoxin concentration
16. Mixed effect modeling of detection and evaluation of drug interaction: Digoxin-qunidine and digoxin-verapamil combinations
17. The diltiazem-digoxin interaction
18. Diltiazem increases steady-state digoxin serum levels in patients with cardiac disease
19. Digoxin plasma concentrations and nifedipine
20. Interaction between digoxin and the calcium antagonists nicardipine and tiapamil
21. Spironolactone-induced changes in digoxin kinetics
22. Digoxin-quinidine-spironolactone interaction
23. Estimation of population pharmacokinetic parameters in the Japanese: Digoxin
24. Digoxin-interactions in man: Spironolactone reduces renal but not biliary digoxin clearance
25. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK)
26. Influence of spironolactone and its metabolite canrenone on serum digoxin assays
27. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data
28. Decreased renal clearance of digoxin in chronic congestive heart failure
29. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: An update